Treatment of aspergillus flavus mycotic corneal ulcer, using natural, synthetic, and surface active materials

Abstract EN

The causative mycotic corneal ulcers Aspergillus flavus has been tested in vitro and in vivo against some antifungal agents.

Cetrimide was the highest inhibitory agent and has been recorded inhibition zone of 5.7 cm in vitro at concentration of 20 mg / ml.

The histopathologically effects of Cetrimide application on corneal tissues on volunteer's ulcers revealed no abnormalities on corneal tissue.

The current results indicate that cetrimide has the highest antifungal activity with no side effects on treatment of A.

flavus corneal ulcers.

In conclusion : cetrimide is a promising antifungal agent for treatment of human A.

flavus mycotic ulcers.